Circadian Technologies (ASX: CIR, OTCQX: CKDXY) managing director and CEO Robert Klupacs has increased his direct interest in the company with an on-market purchase of 23,038 shares for a consideration of $13,362 - for an average entry price of $0.58.
Klupacs now holds a direct interest of 197,519 shares in the Australian biotechnology company, with three lines of 500,000 or more unlisted employee options.
Circadian has entered a very interesting phase - and from last month can now service interest from U.S. based investors after launching a Level 1 American Depositary Receipts (ADR) program and OTCQX quotation.
The dual listing was due to the company receiving interest from U.S. retail orientated broking houses, and also institutions with mandates to invest only in U.S. traded stocks.
Originally published at: http://www.proactiveinvestors.com.au/companies/news/17948/circadian-technologies-managing-director-boosts-stake-with-on-market-purchases-17948.html
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment